• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

WHAM 2026: The Economic Case for Women’s Health Investment

by Jasmine Pennic 01/16/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
WHAM 2026: The Economic Case for Women’s Health Investment

What You Should Know: 

– The 2026 WHAM Investment Report, released at the 44th Annual JPMorgan Healthcare Conference, establishes women’s health as a high-growth precision medicine category. 

– Redefining the market beyond reproductive care, the report provides a roadmap for capital allocation into conditions that affect women exclusively, differently, or disproportionately. It features six in-depth case studies demonstrating real-world commercial success and durable long-term value.

The Economic Catalyst: Quantifying the Return on Investment

Produced in collaboration with the KPMG Foundation and KPMG LLP, the report reframes women’s health from a social advocacy issue to a rigorous economic engine. The data-driven microsimulation models developed by the RAND Corporation for WHAM highlight the profound societal cost of the current “funding gap”.

Redefining the “Bikini Medicine” Paradigm

The report challenges persistent misconceptions that limit capital allocation. For decades, “women’s health” was synonymous with maternal and reproductive care—a paradigm often referred to as “bikini medicine.” WHAM’s 2026 analysis pushes into the “other 95%” where diseases impact women exclusively, differently, or disproportionately.

  • Autoimmune Diseases: 78-80% of patients are women (nearly 40 million), yet women-focused research in rheumatoid arthritis has received as little as 7% of the NIH budget in recent years.
  • Brain Health: 66% of Alzheimer’s patients are women, but historically only 12% of the NIH Alzheimer’s budget focused on women.
  • Heart Health: Women are 50% more likely to die than men in the first year following a heart attack, yet cardiovascular research has historically allocated only 4%–4.5% of its budget to women-focused projects.

“We are at a true inflection point,” said Janet Foutty, Former Chair Deloitte, WHAM Senior Advisor. “The science has matured, the market demand is undeniable, and the economic case is now rigorously quantified. The question for leaders is no longer whether to invest in women’s health—but whether they are prepared to lead as this market rapidly takes shape.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Femtech

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

Aidoc Secures $150M to Accelerate Enterprise-Scale Clinical AI Across 2,000 Hospitals

OpenAI Launches ChatGPT for Clinicians: Free AI Documentation and Research Tool for Verified Physicians

OpenAI Launches ChatGPT for Clinicians: Free AI Documentation and Research Tool for Verified Physicians

IKS Health Acquires TruBridge for Rural EHR and RCM Solutions Expansion

IKS Health Acquires TruBridge for Rural EHR and RCM Solutions Expansion

UT Austin is Building the Nation's First 'AI-Native' Hospital, Backed by $750M

Why UT Austin is Building an ‘AI-Native’ Hospital from Scratch

The Medtech Pitch Deck Casino: Why Hype Still Wins, and How Scrutiny Could Improve Everyone’s Odds

The Casino Model: Why Medtech VCs Are Betting Billions on Unproven AI

Oracle Lays Off 539 Kansas City Employees as Focus Shifts to AI Data Centers

Oracle Lays Off 539 Kansas City Employees as Focus Shifts to AI Data Centers

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

HHS Reverses 2024 Tech Reorganization: Why HHS Just Stripped AI and Cyber Operations Out of the ONC

How Small Medical Practices Can Build HIPAA-Aligned DevSecOps Without Enterprise Budgets

How Small Medical Practices Can Build HIPAA-Aligned DevSecOps Without Enterprise Budgets

Insilico Medicine and Eli Lilly Form $2.75B AI Drug Discovery Collaboration

Insilico Medicine and Eli Lilly Form $2.75B AI Drug Discovery Collaboration

Microsoft Copilot Health, Integrates Apple Health, Oura, and 50,000 EHRs in New AI Push

Microsoft Launches Copilot Health, Integrates Apple Health, Oura, and 50,000 EHRs in New AI Push

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |